Your feedback helps us tailor the treatment to your specific needs, ensuring you get the best possible results
The EDICT study, employing diabetes medications (GLP-1 receptor agonist, pioglitazone, metformin) that correct the basic underlying pathophysiologic defects present in type 2 diabetes, convincingly demonstrated that combination therapy produces a greater and more durable reduction in HbA1c than the treat-to-fail approach using diabetes medications (sulfonylureas, metformin, insulin) that do not correct the basic metabolic and cellular defects (insulin resistance and beta-cell dysfunction) present in type 2 diabetes patients
These bubbles are a normal part of the compounding and storage process and do not reduce the effectiveness of your medication
IV therapy delivers 100% absorption at doses 10-50 times higher, creating therapeutic blood concentrations impossible to achieve orally
Emotional hunger often comes on suddenly, craves specific foods, and may persist even after eating